Rubius gets bump in first day of trading after $241.1M IPO

Cellular therapy company Rubius Therapeutics Inc. (NASDAQ:RUBY) climbed $1.25 to $24.25 in its first day of trading July 18

Read the full 192 word article

User Sign In